Clinical trial
Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced…
NCT00004246 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00004246 |
|---|---|
| Title | Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx |
| Official title | A Phase I Study of Fludarabine With Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Radiation |
| Interventions | Fludarabine Phosphate, Radiation Therapy (RT) |
| Enrollment | 16 |
| Start date | Jun 7, 1995 |
| Primary completion | Dec 2, 2002 |
| Completion | Dec 2, 2002 |
| First posted | May 3, 2004 |
| Last update posted | Oct 25, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: